The power and potential of regenerative medicine

The field of muscle stem cell research has been tangibly developing over the decades and in today’s pharmaphorum podcast wed editor Nicole Raleigh speaks with Dr Michael Rudnicki, co-founder and CSO of Satellos Biosciences, a company dedicated to developing novel therapeutics based on this science for those who live with Duchenne muscular dystrophy (DMD) and other degenerative muscle diseases.

Dr Rudnicki - also a senior scientist and director at the Regenerative Medicine Program and Sprott Centre for Stem Cell Research at the Ottawa Hospital Research Institute - first identified and defined a sub-population of muscle (aka ‘satellite’) stem cells in 2007, capable of self-renewal and regeneration. Talking about the power and potential of regenerative medicine, it is the mechanism – rather the phenomenology – of stem cells that intrigues Rudnicki, as from these mechanisms drug targets can be identified.

You can listen to episode 142a of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series - in iTunes, Spotify, Google Podcasts, Amazon Music, and Podbean.